Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
Do you offer hypofractionated accelerated whole breast radiation therapy for women receiving trastuzumab during RT, particularly those with left sided primaries?
In START B ~ 23 % of women received some form of cytotoxic chemotherapy, and the trial was conducted in the trastuzumab era, but there is no mention of trastuzumab specifically in the publication. Is there any other available data to help guide us in this?
Answer from: Radiation Oncologist at Community Practice
In the modern era for breast RT the radiation field should not be transversing through heart (a conformal block, the prone position or DIBH technique can help prevent radiation to the heart) and with one of these techniques mean heart dose is 1 to 2 Gy (most of this dose comes from scatter or transm...
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
The new ASTRO guideline on whole breast fractionation recently published in Practical Radiation Oncology (PRO) concluded that the decision to offer hypofractionation should be independent of breast laterality and independent of chemotherapy received prior to radiation or trastuzumab or endocrine the...